Month: January 2022
-
Exosomes Shown to Block Broad Covid-19 Variant Range
Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells.
-
Trial Shows Immunotherapy Improves Lung Cancer Survival
Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy.
-
Electric Future of the Global Supply Chain
Several global issues contribute to the current international trade and manufacturing situation.
-
Saliva Test, App for Stress Levels Unveiled
A start-up company is developing a home testing system that combines a saliva test and smartphone app to detect unhealthy stress levels.
-
Plant Science Products Company Raises $6.1M in Early Funds
A maker of products derived from plants for vaccines and control of crop disease is raising $6.1 million in its first venture funding round.
-
Infographic – Venture Funds More Than Double in 2021
Venture funding worldwide rose sharply in 2021, with investment dollars climbing to nearly $621 billion, more than twice the total invested in 2020.
-
Genetics Help Control Dangerous Insects
Advances in genetics are providing communities, businesses, and homeowners with new tools for controlling harmful insects.
-
Spinal Fusion/Stimulation Trial for Back Pain Underway
A clinical trial is underway testing an implanted device providing electronic stimulation along with spinal fusion surgery to treat chronic lower back pain.
-
National Lab, Software Company Partner on Net-Zero Microgrid
Idaho National Laboratory chose an energy software company to design a technology platform for local distribution of non-carbon electrical power.
-
Trial Shows Gut Probiotic Reduces Covid-19 Disease
Results of a clinical trial show a microbial supplement in the gut reduces respiratory symptoms and viral load in people with mild Covid-19 disease.